| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Medical Officer | Common Stock | 198,497 | $7,417,833 | $37.37 | 05 Jan 2024 | Direct |
| Athira Pharma, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 10,189 | $70,100 | $6.88 | 02 Jan 2026 | Direct |
| Athira Pharma, Inc. | CHIEF MEDICAL OFFICER | Restricted Stock Units | 0 | $41,682 | $0.5619 | 31 Dec 2025 | Direct |
| Athira Pharma, Inc. | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | 44,508 | 24 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | 31 Dec 2025 | 3 | -$11,311 | 4 | CHIEF MEDICAL OFFICER | 05 Jan 2026, 19:52 |
| ATHA | Athira Pharma, Inc. | 24 Dec 2025 | 1 | $0 | 4 | CHIEF MEDICAL OFFICER | 29 Dec 2025, 16:14 |
| ATHA | Athira Pharma, Inc. | 30 Jun 2025 | 3 | -$3,182 | 4 | CHIEF MEDICAL OFFICER | 02 Jul 2025, 16:33 |
| ATHA | Athira Pharma, Inc. | 03 Mar 2025 | 2 | $0 | 4 | CHIEF MEDICAL OFFICER | 04 Mar 2025, 16:29 |
| ATHA | Athira Pharma, Inc. | 31 Dec 2024 | 3 | -$6,083 | 4 | CHIEF MEDICAL OFFICER | 03 Jan 2025, 17:05 |
| ATHA | Athira Pharma, Inc. | 01 Oct 2024 | 2 | $0 | 4 | CHIEF MEDICAL OFFICER | 03 Oct 2024, 19:13 |
| ATHA | Athira Pharma, Inc. | 15 Apr 2024 | 1 | $0 | 4 | CHIEF MEDICAL OFFICER | 16 Apr 2024, 16:37 |
| ATHA | Athira Pharma, Inc. | 15 Apr 2024 | 0 | $0 | 3 | CHIEF MEDICAL OFFICER | 16 Apr 2024, 16:34 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 04 Jan 2024 | 4 | -$292,804 | 4 | Chief Medical Officer | 08 Jan 2024, 17:16 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 20 Nov 2023 | 2 | -$567,315 | 4 | Chief Medical Officer | 22 Nov 2023, 14:31 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 04 Jan 2023 | 1 | $0 | 4 | Chief Medical Officer | 05 Jan 2023, 18:18 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 21 Nov 2022 | 2 | -$584,738 | 4 | Chief Medical Officer | 22 Nov 2022, 17:05 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 19 Nov 2021 | 3 | -$1,351,589 | 4 | Chief Medical Officer | 22 Nov 2021, 15:56 |